10-[2-(5-fluoro-1H-indol-3-yl)ethylamino]-2-methyl-2,7-diazatricyclo[6.3.1.04,12]dodeca-1(12),3,7,9-tetraen-11-one | 1025448-65-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 10-[2-(5-fluoro-1H-indol-3-yl)ethylamino]-2-methyl-2,7-diazatricyclo[6.3.1.04,12]dodeca-1(12),3,7,9-tetraen-11-one
• CAS: 1025448-65-0
• 化学式: C₂₁H₁₉FN₄O
• 分子量: 362.406
• InChiKey: RNCZOTSQLSBCAN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  27
• 可旋转键数：
  4
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.24
• 拓扑面积：
  62.2
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  5-氟色胺 、 1,3,4,8-tetrahydro-7-methoxy-1-methyl-8-oxopyrrolo<4,3,2-de>quinoline 以 乙醇 为溶剂， 反应 4.0h， 以48%的产率得到10-[2-(5-fluoro-1H-indol-3-yl)ethylamino]-2-methyl-2,7-diazatricyclo[6.3.1.04,12]dodeca-1(12),3,7,9-tetraen-11-one
  参考文献：
  名称：

  Synthesis and biological evaluation of pyrroloiminoquinone derivatives

  摘要：

  Synthesis of 10 pyrroloiminoquinone derivatives is presented. The strategy is based around the elaboration of a common intermediate by reaction with primary amines. All the compounds obtained have been subjected to antiproliferative activity with three different cell lines (NCI-H460, HeLa, and HL-60). The capacity of 4 selected compounds to affect the enzymatic activity of the nuclear enzyme DNA topoisomerase II and to form the typical DNA fragmentation which occurs in the apoptotic process is discussed here. (C) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2007.11.063

文献信息

• Synthesis and biological evaluation of pyrroloiminoquinone derivatives
  作者：Daniele Passarella、Francesca Belinghieri、Michele Scarpellini、Graziella Pratesi、Franco Zunino、Ornella Maria Gia、Lisa Dalla Via、Giuseppe Santoro、Bruno Danieli

  DOI：10.1016/j.bmc.2007.11.063

  日期：2008.3

  Synthesis of 10 pyrroloiminoquinone derivatives is presented. The strategy is based around the elaboration of a common intermediate by reaction with primary amines. All the compounds obtained have been subjected to antiproliferative activity with three different cell lines (NCI-H460, HeLa, and HL-60). The capacity of 4 selected compounds to affect the enzymatic activity of the nuclear enzyme DNA topoisomerase II and to form the typical DNA fragmentation which occurs in the apoptotic process is discussed here. (C) 2007 Elsevier Ltd. All rights reserved.